Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
Pt 2
pubmed:dateCreated
2002-3-7
pubmed:abstractText
Members of the lipocalin superfamily share a common structural fold, but differ from each other with respect to the molecules with which they interact. They all contain eight beta-strands (A-H) that fold to form a well-defined beta-barrel, which harbours a binding pocket for hydrophobic ligands. These strands are connected by loops that vary in size and structure and make up the closed and open ends of the pocket. In addition to binding ligands, some members of the family interact with other macromolecules, the specificity of which is thought to be associated with the variable loop regions. Here, we have investigated whether the macromolecular-recognition properties can be transferred from one member of the family to another. For this, we chose the prototypical lipocalin, the plasma retinol-binding protein (RBP) and its close structural homologue the epididymal retinoic acid-binding protein (ERABP). RBP exhibits three molecular-recognition properties: it binds to retinol, to transthyretin (TTR) and to a cell-surface receptor. ERABP binds retinoic acid, but whether it interacts with other macromolecules is not known. Here, we show that ERABP does not bind to TTR and the RBP receptor, but when the loops of RBP near the open end of the pocket (L-1, L-2 and L-3, connecting beta-strands A-B, C-D and E-F, respectively) were substituted into the corresponding regions of ERABP, the resulting chimaera acquired the ability to bind TTR and the receptor. L-2 and L-3 were found to be the major determinants of the receptor- and TTR-binding specificities respectively. Thus we demonstrate that lipocalins serve as excellent scaffolds for engineering novel biological functions.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-10051566, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-10052934, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-11058743, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-1331074, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-1731756, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-2165489, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-2401856, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-2611252, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-2849420, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-2849421, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-3368453, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-4718739, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-560371, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-6540172, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-7754382, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-8002949, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-8068012, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-8069623, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-824287, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-8250844, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-8496140, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-9452451, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-9693115, http://linkedlifedata.com/resource/pubmed/commentcorrection/11853533-9849905
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
362
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
265-71
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:11853533-Base Sequence, pubmed-meshheading:11853533-Binding, Competitive, pubmed-meshheading:11853533-Binding Sites, pubmed-meshheading:11853533-Cell Membrane, pubmed-meshheading:11853533-Cloning, Molecular, pubmed-meshheading:11853533-DNA Primers, pubmed-meshheading:11853533-Epididymis, pubmed-meshheading:11853533-Escherichia coli, pubmed-meshheading:11853533-Female, pubmed-meshheading:11853533-Humans, pubmed-meshheading:11853533-Kinetics, pubmed-meshheading:11853533-Male, pubmed-meshheading:11853533-Models, Molecular, pubmed-meshheading:11853533-Molecular Sequence Data, pubmed-meshheading:11853533-Placenta, pubmed-meshheading:11853533-Prealbumin, pubmed-meshheading:11853533-Pregnancy, pubmed-meshheading:11853533-Protein Structure, Secondary, pubmed-meshheading:11853533-Receptors, Retinoic Acid, pubmed-meshheading:11853533-Recombinant Fusion Proteins, pubmed-meshheading:11853533-Retinol-Binding Proteins, pubmed-meshheading:11853533-Retinol-Binding Proteins, Plasma, pubmed-meshheading:11853533-Tretinoin
pubmed:year
2002
pubmed:articleTitle
The transfer of transthyretin and receptor-binding properties from the plasma retinol-binding protein to the epididymal retinoic acid-binding protein.
pubmed:affiliation
School of Biochemistry and Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't